On June 8th and 9th, the partners of the HAPPY PATIENT project gathered in Copenhagen to assess the progress of this project, which started in 2021 and will run until the end of this year, 2023. Around thirty professionals from different parts of Europe gathered at the University of Copenhagen...
News
FeaturedProfessor Lars Bjerrum highlights the role of the IDIAPJGol in European research projects
Last week, the Research Institute in Primary Healthcare IDIAPJGol and the Catalan Institute of Health (ICS) presented their Annual Awards for "Research in Primary Health Care IDIAPJGol-ICS". A total of 23 researchers were awarded in different categories.
FeaturedEuropean Commission proposes a unified market for medicines and incentives for antibiotic development to address drug shortages in EU
The European Commission has recently put forth a proposal to amend the EU pharmaceutical legislation on April 26, 2023 (available at https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf). This proposed revision aims to establish a unified market for medicines across all EU member states, thereby promoting greater accessibility to novel and effective drugs while also tackling...
FeaturedWHO warns of too few new drugs for deadly superbugs
The WHO has called on governments and pharmaceutical companies to invest in research and development of new antibiotics and has also recommended that antibiotics be used more judiciously to prevent the emergence of drug-resistant bacteria.
FeaturedSpain becomes a benchmark in Europe in the fight against antimicrobial resistance thanks to PROA certification standard
Global increase in antimicrobial resistance and complexity of infectious disease make it essential to establish Antimicrobial Use Optimization Programs (PROA) in the community and hospital areas. These programs have the objective of optimizing prescription of antibiotics, guaranteeing optimal clinical results, minimizing adverse effects derived from their use, controlling the appearance...
FeaturedResults, interventions, and qualitative studies debates at the second HAPPY PATIENT face-to-face meeting
Organized by the consortium partner, Universidad de las Palmas de Gran Canaria, and its Fundación Parque Tecnológico, the meeting highlighted the work done in recent months and designed the strategies for the final section of the project. The afternoon of the first day of the meeting, January 26, 2023, was...
FeaturedMore than 400 European experts
participate in the project HAPPY PATIENT
to optimize the use of antibiotics
• One of the research lines of the HAPPY PATIENT European project is to develop a strategy to improve communication between professionals and patients. • As the celebration of the European Day for the Prudent Use of Antibiotics approaches on November 18, it is worth remembering that the adequacy of...
Lithuania kicked off the HAPPY PATIENT training interventions for trainers
Last 11 November about 40 health care professionals - mostly family doctors/general practitioners participated in the first training of the project On November 11, the Lithuanian colleagues of the HAPPY PATIENT project carried out their first intervention in the country. During it, the communication materials made by the consortium were...
“A good use of communication reduces the
arbitrary prescription of antibiotics by 25-30%”
The first session of the HAPPY PATIENT Communication skills: Training the trainers for the countries taking part in the project took place yesterday, 13 September afternoon. The topic addressed was the need to integrate communication skills into clinical practice and, more specifically, when deciding on the prescription of antibiotics. Nieves Barragán and Lucía Arias, as members of the Spanish Society of Family and...
These are the HAPPY PATIENT tools to fight
antimicrobial resistance with communication
The HAPPY PATIENT European project, The Health Alliance for Prudent Prescription and Yield of Antibiotics from a Patient-Centred Perspective, has taken another step forward in its goal of reducing the arbitrary prescription of antibiotics in 4 target countries of the European Union where this type of prescription is higher (Spain, France, Greece and Poland,...